Other
Clinical Efficacy and Safety
0
Pipeline Programs↗
4
Active Trials↗
7
Companies Involved↗
Clinical Efficacy and Safety is an early-stage landscape with 0 programs across 7 companies. The most active players are Hanmi Pharmaceutical Company Limited, Chengdu Easton Biopharmaceuticals Co,Ltd, Shanghai Biomabs Pharmaceutical Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
27
clinical trials
Completed13 · 48%
Unknown status8 · 30%
Recruiting2 · 7%
Terminated2 · 7%
Not yet recruiting1 · 4%
Active, not recruiting1 · 4%
Clinical Trials
Trial Activity
27 trials
Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients
Recruiting·—·Phase 2·NCT07338344·78 enrolled
Clinical Efficacy and Safety of Tender Point Infiltration (TPI) for Acute and Subacute Zoster Associated Pain
Active, not recruiting·—·N/A·NCT06344403·136 enrolled
Clinical Efficacy and Safety of Loxacon Dietary Supplement Capsules at Patients With Knee Arthrosis
Completed·PPolyclinic of the Hospitaller Brothers of St. John of God, Budapest·Phase 4·NCT05925725·100 enrolled
Clinical Efficacy and Safety of Metformin Versus Apple Cider Vinegar (ACV) in Prediabetics
Completed·—·N/A·NCT05759442·46 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)